Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Treatment of Candida glabrata Infections

Systemic C. glabrata Infections

  • The Infectious Diseases Society of America recommends echinocandins as first-line therapy for systemic C. glabrata infections due to intrinsic azole resistance in this species 1, 2
  • For fluconazole-resistant C. glabrata, amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days with or without oral flucytosine (25 mg/kg 4 times daily) is recommended 1
  • Echinocandins (e.g., caspofungin) are preferred for C. glabrata infections as they demonstrate good activity against this species 2

Urinary Tract Infections

  • For C. glabrata cystitis, amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR oral flucytosine 25 mg/kg 4 times daily for 7-10 days is recommended 1
  • Amphotericin B bladder irrigation (50 mg/L sterile water daily for 5 days) may be useful for treating cystitis due to fluconazole-resistant C. glabrata 1
  • Removal of indwelling bladder catheters is strongly recommended whenever feasible 1

Vulvovaginal C. glabrata Infections

  • For C. glabrata vulvovaginitis unresponsive to oral azoles, topical intravaginal boric acid administered in a gelatin capsule, 600 mg daily for 14 days is recommended 3, 4, 5
  • Nystatin intravaginal suppositories, 100,000 units daily for 14 days, are an alternative treatment option 3, 4, 5
  • Topical 17% flucytosine cream alone or in combination with 3% amphotericin B cream administered daily for 14 days is another alternative treatment 3, 4, 5

Special Considerations

  • C. glabrata often has reduced susceptibility to azoles, particularly fluconazole 2
  • Removal of infected devices (catheters, shunts, etc.) is crucial for successful treatment 1